Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date - PubMed (original) (raw)
Review
Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date
Mary R Lee et al. CNS Drugs. 2016 Feb.
Abstract
The neuropeptide oxytocin plays a role in reward, stress, social affiliation, learning, and memory processes. As such, there is increasing interest in oxytocin as a potential treatment for addictions. The endogenous oxytocin system is itself altered by short- or long-term exposure to drugs of abuse. A large number of preclinical studies in rodents have investigated the effect of oxytocin administration on various drug-induced behaviors to determine whether oxytocin can reverse the neuroadaptations occurring with repeated drug and alcohol use. In addition, the mechanisms by which oxytocin acts to modify the behavioral response to drugs of abuse are beginning to be understood. More recently, a few small clinical studies have been conducted in cocaine, cannabis, and alcohol dependence. This review summarizes the preclinical as well as clinical literature to date on the oxytocin system and its relevance to drug and alcohol addiction.
Similar articles
- The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.
Bowen MT, Neumann ID. Bowen MT, et al. Curr Top Behav Neurosci. 2018;35:269-287. doi: 10.1007/7854_2017_17. Curr Top Behav Neurosci. 2018. PMID: 28942596 Review. - Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
Bowen MT, Neumann ID. Bowen MT, et al. Trends Neurosci. 2017 Dec;40(12):691-708. doi: 10.1016/j.tins.2017.10.003. Epub 2017 Nov 8. Trends Neurosci. 2017. PMID: 29128108 Review. - From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
McGregor IS, Callaghan PD, Hunt GE. McGregor IS, et al. Br J Pharmacol. 2008 May;154(2):358-68. doi: 10.1038/bjp.2008.132. Br J Pharmacol. 2008. PMID: 18475254 Free PMC article. Review. - Oxytocin and Rodent Models of Addiction.
Leong KC, Cox S, King C, Becker H, Reichel CM. Leong KC, et al. Int Rev Neurobiol. 2018;140:201-247. doi: 10.1016/bs.irn.2018.07.007. Epub 2018 Aug 14. Int Rev Neurobiol. 2018. PMID: 30193705 Free PMC article. Review. - Oxytocin for the treatment of drug and alcohol use disorders.
Lee MR, Weerts EM. Lee MR, et al. Behav Pharmacol. 2016 Dec;27(8):640-648. doi: 10.1097/FBP.0000000000000258. Behav Pharmacol. 2016. PMID: 27603752 Free PMC article. Review.
Cited by
- Brain proteomic atlas of alcohol use disorder in adult males.
Teng PN, Barakat W, Tran SM, Tran ZM, Bateman NW, Conrads KA, Wilson KN, Oliver J, Gist G, Hood BL, Zhou M, Maxwell GL, Leggio L, Conrads TP, Lee MR. Teng PN, et al. Transl Psychiatry. 2023 Oct 13;13(1):318. doi: 10.1038/s41398-023-02605-0. Transl Psychiatry. 2023. PMID: 37833300 Free PMC article. - Increase of orexin A in the peripheral blood of adolescents with Internet gaming disorder.
Choi MR, Cho H, Chun JW, Yoo JH, Kim DJ. Choi MR, et al. J Behav Addict. 2020 Apr 1;9(1):93-104. doi: 10.1556/2006.8.2019.65. J Behav Addict. 2020. PMID: 31957460 Free PMC article. - Prolonged efavirenz exposure reduces peripheral oxytocin and vasopressin comparable to known drugs of addiction in male Sprague Dawley rats.
Le Roux M, Möller M, Harvey BH. Le Roux M, et al. IBRO Neurosci Rep. 2021 Jun 26;11:56-63. doi: 10.1016/j.ibneur.2021.06.003. eCollection 2021 Dec. IBRO Neurosci Rep. 2021. PMID: 34939063 Free PMC article. - A randomized controlled trial examining the effects of intranasal oxytocin on alcohol craving and intimate partner aggression among couples.
Flanagan JC, Nietert PJ, Sippel L, Jarnecke AM, Kirby C, Hogan JN, Massa AA, Brower J, Back SE, Parrott D. Flanagan JC, et al. J Psychiatr Res. 2022 Aug;152:14-24. doi: 10.1016/j.jpsychires.2022.06.011. Epub 2022 Jun 9. J Psychiatr Res. 2022. PMID: 35709548 Free PMC article. Clinical Trial. - Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.
Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD. Stauffer CS, et al. Alcohol Clin Exp Res. 2019 Dec;43(12):2627-2636. doi: 10.1111/acer.14217. Epub 2019 Nov 6. Alcohol Clin Exp Res. 2019. PMID: 31610033 Free PMC article. Clinical Trial.
References
- Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nature reviews Neuroscience. 2011;12(9):524–38. - PubMed
- Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nature reviews Neuroscience. 2006;7(2):126–36. - PubMed
- Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiological reviews. 2001;81(2):629–83. - PubMed
- Stoop R. Neuromodulation by oxytocin and vasopressin in the central nervous system as a basis for their rapid behavioral effects. Current opinion in neurobiology. 2014;29:187–93. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials